Skip to main content
SpringerLink
Log in

Sildenafil cost effective for PAH in Canada

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2013 Canadian dollars

Reference

  • Coyle K, et al. Cost Effectiveness of First-Line Oral Therapies for Pulmonary Arterial Hypertension: A Modelling Study. PharmacoEconomics : 6 Jan 2016. Available from: URL: http://doi.org/10.1007/s40273-015-0366-8

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sildenafil cost effective for PAH in Canada. PharmacoEcon Outcomes News 745, 31 (2016). https://doi.org/10.1007/s40274-016-2772-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-2772-3

Search

Navigation